American Equity Ramps Private Asset Allocation to 22% and Achieves Close to $10 billion in Fee-Generating Reinsurance Balances in Fourth Quarter 2022
American Equity Investment Life Holding Company (AEL) reported a Q4 2022 net loss of $(29.4) million, or $(0.34) per diluted share, a stark contrast to a net income of $82.2 million, or $0.88 per share in Q4 2021. Non-GAAP operating income fell to $67.9 million, or $0.79 per share, from $75.8 million in the same quarter last year. The company sourced approximately $1.4 billion in private assets, increasing total portfolio allocation to 22%. Q4 FIA sales grew 7% sequentially to $783 million. Despite a decline in investment returns, AEL's management expressed confidence in their AEL 2.0 strategy and forecast continued long-term shareholder value.
- Sourced $1.4 billion in private assets, increasing investment portfolio allocation to 22%.
- Q4 FIA sales rose 7% sequentially to $783 million.
- Non-GAAP operating income of $67.9 million, demonstrating operational resilience.
- Strategic partnership with 26North Re adds to recurring fee revenues and account value growth.
- Q4 2022 net loss of $(29.4) million compared to net income of $82.2 million in Q4 2021.
- Non-GAAP operating income decreased from $75.8 million in Q4 2021 to $67.9 million in Q4 2022.
- Lower than expected investment returns impacted overall portfolio yield by 9 basis points.
Company Highlights
-
Q4 2022 net loss available to common stockholders of
, or$(29.4) million per diluted common share compared to net income of$(0.34) , or$82.2 million per diluted common share for Q4 2021$0.88
-
Non-GAAP operating income1 available to common stockholders for the fourth quarter 2022 was
, or$67.9 million per diluted common share; No notable items impacted results in the quarter$0.79
-
Private asset deployment momentum continues with approximately
sourced in the quarter bringing total portfolio allocation to$1.4 billion 22%
-
Sequential quarterly FIA sales increase of
7% to$783 million
-
Ceded
of flow reinsurance to Brookfield Re and$352 million of GAAP reserves, including$4.3 billion of account value, in new strategic partnership with 26North Re increasing "fee-like" revenues and growing account value subject to recurring fees to$3.8 billion $9.6 billion
American Equity's President and CEO,
Bhalla continued, “While fourth quarter results reflect lower-than-expected investment returns on mark-to-market assets, impacting overall portfolio yield by 9 basis points, our strong execution on our AEL 2.0 strategy over the last year, as well as the sales momentum we are seeing through the first six weeks of 2023, only increase our confidence in our continued delivery of superior shareholder value this year and over the long term.”
Non-GAAP operating income1 available to common stockholders for the fourth quarter of 2022 was
Actuarial assumption revisions utilized in the determination of deferred policy acquisition costs, deferred sales inducements, and the liability for future policy benefits to be paid for guaranteed lifetime income through life-time income benefit riders (LIBR) negatively affected non-GAAP operating income1 by
The year-over-year change in quarterly non-GAAP operating income1 available to common stockholders excluding the impact of actuarial assumption revisions primarily reflected the effect of reduced equity index credits due to the decline in equity markets on the increase in the LIBR reserve and in the amortization of the deferred acquisition cost and deferred sales inducement assets. This was offset partly by substantial increases in both investment spread and recurring fee revenue associated with reinsurance.
For the fourth quarter of 2022, net investment income increased
Compared to the fourth quarter of 2021, the change in the liability for future benefits to be paid for LIBR increased
Compared to the fourth quarter of 2021, amortization of deferred policy acquisition and sales inducement cost increased
As of
The effective tax rate on pre-tax operating income1 for the fourth quarter of 2022 was
STRONG INVESTED ASSET ORIGINATION AT ATTRACTIVE EXPECTED RATES OF RETURN
American Equity’s investment spread was
Average yield on invested assets was
During the quarter, investment asset purchases totaled
The aggregate cost of money for annuity liabilities of
Fourth quarter sales were
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
The forward-looking statements in this release or that American Equity uses on its conference call, such as ability, aim, anticipate, assume, become, believe, building, can, commit, constructive, continue, could, estimate, expect, exposure, forward, future, goal, grow, guidance, intend, likely, look to, may, might, model, opportunity, outlook, over time, plan, potential, prepare, project, ramp, risk, scenario, see, should, signal, strategy, target, to be, toward, trends, will, would, and their derivative forms and similar words, as well as any projections of future results, are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" the company describes in its
CONFERENCE CALL
American Equity will hold a conference call to discuss fourth quarter 2022 earnings on
The conference call will be webcast live on the Internet. Investors and interested parties who wish to listen to the webcast may register to access it on our IR website at https://ir.american-equity.com. An audio replay will also be available via the same link on our website shortly after the completion of the call for 30 days.
The call may also be accessed by telephone. Investors and interested parties may register for the call with the form available at this link, and upon submission (and via follow-up email) will receive the dial-in number and a unique PIN to access the call. Registration is available now or any time up to and during the time of the call. Registration is also available by visiting our IR website at https://ir.american-equity.com.
ABOUT AMERICAN EQUITY
At
1 |
Use of non-GAAP financial measures, including those that isolate notable items, is discussed in this release in the tables that follow the text of the release. |
2 |
Non-trendable items are the impact of investment yield – additional prepayment income and cost of money effect of over (under) hedging as shown in our |
3 |
For the purposes of this document, all references to sales are on a gross basis. Gross sales is defined as sales before the use of reinsurance. |
|
|
Unaudited (Dollars in thousands, except per share data) |
Consolidated Statements of Operations
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenues: |
|
|
|
|
|
|
|
||||||||
Premiums and other considerations |
$ |
2,991 |
|
|
$ |
14,553 |
|
|
$ |
19,739 |
|
|
$ |
58,202 |
|
Annuity product charges |
|
61,666 |
|
|
|
60,310 |
|
|
|
230,354 |
|
|
|
242,631 |
|
Net investment income |
|
537,995 |
|
|
|
514,599 |
|
|
|
2,307,463 |
|
|
|
2,037,475 |
|
Change in fair value of derivatives |
|
22,243 |
|
|
|
522,251 |
|
|
|
(1,138,128 |
) |
|
|
1,348,735 |
|
Net realized gains (losses) on investments |
|
14,411 |
|
|
|
(10,478 |
) |
|
|
(47,848 |
) |
|
|
(13,242 |
) |
Other revenue |
|
15,148 |
|
|
|
8,026 |
|
|
|
43,921 |
|
|
|
15,670 |
|
Total revenues |
|
654,454 |
|
|
|
1,109,261 |
|
|
|
1,415,501 |
|
|
|
3,689,471 |
|
|
|
|
|
|
|
|
|
||||||||
Benefits and expenses: |
|
|
|
|
|
|
|
||||||||
Insurance policy benefits and change in future policy benefits |
|
5,663 |
|
|
|
16,975 |
|
|
|
31,099 |
|
|
|
67,983 |
|
Interest sensitive and index product benefits |
|
160,243 |
|
|
|
574,816 |
|
|
|
889,650 |
|
|
|
2,681,406 |
|
Amortization of deferred sales inducements |
|
46,773 |
|
|
|
59,409 |
|
|
|
408,548 |
|
|
|
152,692 |
|
Change in fair value of embedded derivatives |
|
342,409 |
|
|
|
186,802 |
|
|
|
(2,352,598 |
) |
|
|
(358,302 |
) |
Interest expense on notes and loan payable |
|
10,228 |
|
|
|
6,259 |
|
|
|
32,098 |
|
|
|
25,581 |
|
Interest expense on subordinated debentures |
|
1,335 |
|
|
|
1,330 |
|
|
|
5,331 |
|
|
|
5,324 |
|
Amortization of deferred policy acquisition costs |
|
64,338 |
|
|
|
82,999 |
|
|
|
615,300 |
|
|
|
268,328 |
|
Other operating costs and expenses |
|
62,041 |
|
|
|
66,279 |
|
|
|
239,616 |
|
|
|
243,712 |
|
Total benefits and expenses |
|
693,030 |
|
|
|
994,869 |
|
|
|
(130,956 |
) |
|
|
3,086,724 |
|
Income (loss) before income taxes |
|
(38,576 |
) |
|
|
114,392 |
|
|
|
1,546,457 |
|
|
|
602,747 |
|
Income tax expense (benefit) |
|
(20,478 |
) |
|
|
21,255 |
|
|
|
325,155 |
|
|
|
128,755 |
|
Net income (loss) |
|
(18,098 |
) |
|
|
93,137 |
|
|
|
1,221,302 |
|
|
|
473,992 |
|
Less: Net income available to noncontrolling interests |
|
361 |
|
|
|
— |
|
|
|
358 |
|
|
|
— |
|
Net income (loss) available to |
|
(18,459 |
) |
|
|
93,137 |
|
|
|
1,220,944 |
|
|
|
473,992 |
|
Less: Preferred stock dividends |
|
10,919 |
|
|
|
10,919 |
|
|
|
43,675 |
|
|
|
43,675 |
|
Net income (loss) available to |
$ |
(29,378 |
) |
|
$ |
82,218 |
|
|
$ |
1,177,269 |
|
|
$ |
430,317 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per common share |
$ |
(0.34 |
) |
|
$ |
0.89 |
|
|
$ |
13.00 |
|
|
$ |
4.58 |
|
Earnings (loss) per common share - assuming dilution |
$ |
(0.34 |
) |
|
$ |
0.88 |
|
|
$ |
12.86 |
|
|
$ |
4.55 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding (in thousands): |
|
|
|
|
|
|
|
||||||||
Earnings (loss) per common share |
|
85,274 |
|
|
|
92,479 |
|
|
|
90,558 |
|
|
|
93,860 |
|
Earnings (loss) per common share - assuming dilution |
|
86,402 |
|
|
|
93,378 |
|
|
|
91,538 |
|
|
|
94,491 |
|
NON-GAAP FINANCIAL MEASURES
In addition to net income (loss) available to common stockholders, we have consistently utilized non-GAAP operating income available to common stockholders and non-GAAP operating income available to common stockholders per common share - assuming dilution, non-GAAP financial measures commonly used in the life insurance industry, as economic measures to evaluate our financial performance. Non-GAAP operating income available to common stockholders equals net income (loss) available to common stockholders adjusted to eliminate the impact of items that fluctuate from quarter to quarter in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at non-GAAP operating income available to common stockholders eliminate the impact of fair value accounting for our fixed index annuity business. These adjustments are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of non-GAAP operating income available to common stockholders together with net income (loss) available to common stockholders provides information that may enhance an investor’s understanding of our underlying results and profitability.
Reconciliation from Net Income (Loss) Available to Common Stockholders to Non-GAAP Operating Income Available to Common Stockholders and Non-GAAP Operating Income Available to Common Stockholders, Excluding Notable Items
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net income (loss) available to |
$ |
(29,378 |
) |
|
$ |
82,218 |
|
|
$ |
1,177,269 |
|
|
$ |
430,317 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Net realized (gains) losses on financial assets, including credit losses (a) |
|
(15,167 |
) |
|
|
7,771 |
|
|
|
36,428 |
|
|
|
10,299 |
|
Change in fair value of derivatives and embedded derivatives (a) |
|
138,966 |
|
|
|
(14,544 |
) |
|
|
(1,080,356 |
) |
|
|
(187,290 |
) |
Net investment income (a) |
|
664 |
|
|
|
— |
|
|
|
664 |
|
|
|
— |
|
Other revenue |
|
5,969 |
|
|
|
— |
|
|
|
5,969 |
|
|
|
— |
|
Income taxes |
|
(33,154 |
) |
|
|
383 |
|
|
|
222,966 |
|
|
|
37,184 |
|
Non-GAAP operating income available to common stockholders |
|
67,900 |
|
|
|
75,828 |
|
|
|
362,940 |
|
|
|
290,510 |
|
Impact of excluding notable items (b) |
|
— |
|
|
|
21,235 |
|
|
|
(26,572 |
) |
|
|
78,036 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
67,900 |
|
|
$ |
97,063 |
|
|
$ |
336,368 |
|
|
$ |
368,546 |
|
|
|
|
|
|
|
|
|
||||||||
Per common share - assuming dilution: |
|
|
|
|
|
|
|
||||||||
Net income (loss) available to |
$ |
(0.34 |
) |
|
$ |
0.88 |
|
|
$ |
12.86 |
|
|
$ |
4.55 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Net realized (gains) losses on financial assets, including credit losses |
|
(0.18 |
) |
|
|
0.08 |
|
|
|
0.40 |
|
|
|
0.11 |
|
Change in fair value of derivatives and embedded derivatives |
|
1.61 |
|
|
|
(0.15 |
) |
|
|
(11.80 |
) |
|
|
(1.98 |
) |
Net investment income |
|
0.01 |
|
|
|
— |
|
|
|
0.01 |
|
|
|
— |
|
Other revenue |
|
0.07 |
|
|
|
— |
|
|
|
0.06 |
|
|
|
— |
|
Income taxes |
|
(0.38 |
) |
|
|
— |
|
|
|
2.43 |
|
|
|
0.39 |
|
Non-GAAP operating income available to common stockholders |
|
0.79 |
|
|
|
0.81 |
|
|
|
3.96 |
|
|
|
3.07 |
|
Impact of excluding notable items |
|
— |
|
|
|
0.23 |
|
|
|
(0.29 |
) |
|
|
0.83 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
0.79 |
|
|
$ |
1.04 |
|
|
$ |
3.67 |
|
|
$ |
3.90 |
|
Notable Items
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Notable items impacting non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Impact of actuarial assumption updates |
$ |
— |
|
$ |
(21,235 |
) |
|
$ |
26,572 |
|
$ |
(78,036 |
) |
||
Total notable items (b) |
$ |
— |
|
|
$ |
(21,235 |
) |
|
$ |
26,572 |
|
|
$ |
(78,036 |
) |
(a) |
Adjustments to net income (loss) available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Book Value per Common Share
|
Q4 2022 |
||
Total stockholders’ equity attributable to |
$ |
3,169,223 |
|
Equity available to preferred stockholders (a) |
|
(700,000 |
) |
Total common stockholders' equity (b) |
|
2,469,223 |
|
Accumulated other comprehensive (income) loss (AOCI) |
|
2,155,055 |
|
Total common stockholders’ equity excluding AOCI (b) |
|
4,624,278 |
|
Net impact of fair value accounting for derivatives and embedded derivatives |
|
(1,150,532 |
) |
Total common stockholders’ equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
3,473,746 |
|
|
|
||
Common shares outstanding |
|
84,810,255 |
|
|
|
||
Book Value per Common Share: (c) |
|
||
Book value per common share |
$ |
29.11 |
|
Book value per common share excluding AOCI (b) |
$ |
54.52 |
|
Book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
40.96 |
|
(a) |
Equity available to preferred stockholders is equal to the redemption value of outstanding preferred stock plus share dividends declared but not yet issued. |
(b) |
Total common stockholders' equity, total common stockholders' equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, exclude equity available to preferred stockholders. Total common stockholders’ equity and book value per common share excluding AOCI, non-GAAP financial measures, are based on common stockholders’ equity excluding the effect of AOCI. Since AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale securities, we believe these non-GAAP financial measures provide useful supplemental information. Total common stockholders' equity and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, are based on common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives. Since the net impact of fair value accounting for our derivatives and embedded derivatives fluctuates from quarter to quarter and the most significant impacts relate to fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results, we believe these non-GAAP financial measures provide useful supplemental information. |
(c) |
Book value per common share including and excluding AOCI and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives are calculated as total common stockholders’ equity, total common stockholders’ equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives divided by the total number of shares of common stock outstanding. |
NON-GAAP FINANCIAL MEASURES
Average Common Stockholders' Equity and Return on Average Common Stockholders' Equity
Return on average common stockholders' equity measures how efficiently we generate profits from the resources provided by our net assets. Return on average common stockholders' equity is calculated by dividing net income available to common stockholders, for the trailing twelve months, by average equity available to common stockholders. Non-GAAP operating return on average common stockholders' equity excluding average accumulated other comprehensive income (AOCI) and average net impact of fair value accounting for derivatives and embedded derivatives is calculated by dividing non-GAAP operating income available to common stockholders, for the trailing twelve months, by average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives. We exclude AOCI because AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale investments. We exclude the net impact of fair value accounting for derivatives and embedded derivatives as the amounts are not economic in nature but rather impact the timing of reported results.
|
Twelve Months Ended |
||
|
|
||
Average Common Stockholders' Equity Attributable to |
|
||
Average total stockholders’ equity |
$ |
4,746,175 |
|
Average equity available to preferred stockholders |
|
(700,000 |
) |
Average equity available to common stockholders |
|
4,046,175 |
|
Average AOCI |
|
153,133 |
|
Average common stockholders' equity excluding average AOCI |
|
4,199,308 |
|
Average net impact of fair value accounting for derivatives and embedded derivatives |
|
(712,757 |
) |
Average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives |
|
3,486,551 |
|
Impact of excluding notable items on average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives |
|
(13,286 |
) |
Average common stockholders' equity excluding average AOCI, average net impact of fair value accounting for derivatives and embedded derivatives and notables |
$ |
3,473,265 |
|
|
|
||
Net income available to |
$ |
1,177,269 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
||
Net realized losses on financial assets, including credit losses |
|
36,428 |
|
Change in fair value of derivatives and embedded derivatives |
|
(1,080,356 |
) |
Net investment income |
|
664 |
|
Other revenue |
|
5,969 |
|
Income taxes |
|
222,966 |
|
Non-GAAP operating income available to common stockholders |
|
362,940 |
|
Impact of excluding notable items (b) |
|
(26,572 |
) |
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
336,368 |
|
|
|
||
Return on Average Common Stockholders' Equity Attributable to |
|
||
Net income available to common stockholders |
|
29.1 |
% |
|
|
||
Return on Average Common Stockholders' Equity Attributable to |
|
||
Non-GAAP operating income available to common stockholders |
|
10.4 |
% |
Non-GAAP operating income available to common stockholders, excluding notable items |
|
9.7 |
% |
Notable Items |
Twelve Months Ended |
||
|
|
||
Notable items impacting non-GAAP operating income available to common stockholders: |
|
||
Impact of actuarial assumption updates |
$ |
26,572 |
|
Total notable items (b) |
$ |
26,572 |
|
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230216005801/en/
(515) 273-3763, sschwartz@american-equity.com
Source:
FAQ
What were American Equity Life's Q4 2022 earnings results?
How did AEL's FIA sales perform in Q4 2022?
What is the AEL 2.0 strategy mentioned in the press release?
What impact did the investment returns have on AEL's financial performance?